Page last updated: 2024-11-11
noviose
Description
noviose: is a key synthon for the construction of novobiocin, a clinically useful antitumor agent; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
noviose : A deoxyhexose derivative that is 5-methylhexanal which has been substituted at position 4 by a methoxy group and at positions 2, 3, and 5 by hydroxy groups (the 2R,3S,4R stereoisomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
Synonyms (8)
Synonym |
6-deoxy-5-c-methyl-4-o-methyl-l-lyxo-hexose |
CHEBI:31012 |
(2r,3s,4r)-2,3,5-trihydroxy-4-methoxy-5-methylhexanal |
c-5,c-5,o-4-trimethyl-l-lyxose |
noviose |
l-noviose |
Q27114062 |
114129-09-8 |
Research Excerpts
Overview
Noviose is a key synthon for the construction of novobiocin, a clinically useful antitumor agent. Noviose has been shown to inhibit both type II topoisomerases and Hsp90.
Drug Classes (1)
Class | Description |
deoxyhexose derivative | A deoxy sugar derivative that is formally obtained from a deoxyhexose. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.92
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.92 (24.57) | Research Supply Index | 2.20 (2.92) | Research Growth Index | 4.12 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |